These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34990412)

  • 1. 4PBA reduces growth deficiency in osteogenesis imperfecta by enhancing transition of hypertrophic chondrocytes to osteoblasts.
    Scheiber AL; Wilkinson KJ; Suzuki A; Enomoto-Iwamoto M; Kaito T; Cheah KS; Iwamoto M; Leikin S; Otsuru S
    JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34990412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoplasmic reticulum stress is induced in growth plate hypertrophic chondrocytes in G610C mouse model of osteogenesis imperfecta.
    Scheiber AL; Guess AJ; Kaito T; Abzug JM; Enomoto-Iwamoto M; Leikin S; Iwamoto M; Otsuru S
    Biochem Biophys Res Commun; 2019 Jan; 509(1):235-240. PubMed ID: 30579604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rapamycin on bone mass and strength in the α2(I)-G610C mouse model of osteogenesis imperfecta.
    Bateman JF; Sampurno L; Maurizi A; Lamandé SR; Sims NA; Cheng TL; Schindeler A; Little DG
    J Cell Mol Med; 2019 Mar; 23(3):1735-1745. PubMed ID: 30597759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chaperone activity of 4PBA ameliorates the skeletal phenotype of Chihuahua, a zebrafish model for dominant osteogenesis imperfecta.
    Gioia R; Tonelli F; Ceppi I; Biggiogera M; Leikin S; Fisher S; Tenedini E; Yorgan TA; Schinke T; Tian K; Schwartz JM; Forte F; Wagener R; Villani S; Rossi A; Forlino A
    Hum Mol Genet; 2017 Aug; 26(15):2897-2911. PubMed ID: 28475764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoblast Malfunction Caused by Cell Stress Response to Procollagen Misfolding in α2(I)-G610C Mouse Model of Osteogenesis Imperfecta.
    Mirigian LS; Makareeva E; Mertz EL; Omari S; Roberts-Pilgrim AM; Oestreich AK; Phillips CL; Leikin S
    J Bone Miner Res; 2016 Aug; 31(8):1608-1616. PubMed ID: 26925839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of carbamazepine on bone structure and strength in control and osteogenesis imperfecta (Col1a2
    Blank M; McGregor NE; Rowley L; Kung LHW; Crimeen-Irwin B; Poulton IJ; Walker EC; Gooi JH; Lamandé SR; Sims NA; Bateman JF
    J Cell Mol Med; 2022 Jul; 26(14):4021-4031. PubMed ID: 35701367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-PBA Treatment Improves Bone Phenotypes in the Aga2 Mouse Model of Osteogenesis Imperfecta.
    Duran I; Zieba J; Csukasi F; Martin JH; Wachtell D; Barad M; Dawson B; Fafilek B; Jacobsen CM; Ambrose CG; Cohn DH; Krejci P; Lee BH; Krakow D
    J Bone Miner Res; 2022 Apr; 37(4):675-686. PubMed ID: 34997935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Sox9 and FGF signaling gene expression in Aga2 OI mice negatively affects linear growth.
    Zieba J; Nevarez L; Wachtell D; Martin JH; Kot A; Wong S; Cohn DH; Krakow D
    JCI Insight; 2023 Nov; 8(21):. PubMed ID: 37796615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Fracture Healing is Delayed in the Col1a2
    Besio R; Maruelli S; Battaglia S; Leoni L; Villani S; Layrolle P; Rossi A; Trichet V; Forlino A
    Calcif Tissue Int; 2018 Dec; 103(6):653-662. PubMed ID: 30076439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting cellular stress in vitro improves osteoblast homeostasis, matrix collagen content and mineralization in two murine models of osteogenesis imperfecta.
    Garibaldi N; Contento BM; Babini G; Morini J; Siciliani S; Biggiogera M; Raspanti M; Marini JC; Rossi A; Forlino A; Besio R
    Matrix Biol; 2021 Apr; 98():1-20. PubMed ID: 33798677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Genetic and Pharmacologic Inhibition of Myostatin in a Murine Model of Osteogenesis Imperfecta.
    Omosule CL; Gremminger VL; Aguillard AM; Jeong Y; Harrelson EN; Miloscio L; Mastaitis J; Rafique A; Kleiner S; Pfeiffer FM; Zhang A; Schulz LC; Phillips CL
    J Bone Miner Res; 2021 Apr; 36(4):739-756. PubMed ID: 33249643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schnurri-3 inhibition rescues skeletal fragility and vascular skeletal stem cell niche pathology in the OIM model of osteogenesis imperfecta.
    Li N; Shi B; Li Z; Han J; Sun J; Huang H; Yallowitz AR; Bok S; Xiao S; Wu Z; Chen Y; Xu Y; Qin T; Huang R; Zheng H; Shen R; Meng L; Greenblatt MB; Xu R
    Bone Res; 2024 Aug; 12(1):46. PubMed ID: 39183236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral properties in growing Col1a2(+/G610C) mice, an animal model of osteogenesis imperfecta.
    Masci M; Wang M; Imbert L; Barnes AM; Spevak L; Lukashova L; Huang Y; Ma Y; Marini JC; Jacobsen CM; Warman ML; Boskey AL
    Bone; 2016 Jun; 87():120-9. PubMed ID: 27083399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta.
    Jones GN; Moschidou D; Abdulrazzak H; Kalirai BS; Vanleene M; Osatis S; Shefelbine SJ; Horwood NJ; Marenzana M; De Coppi P; Bassett JH; Williams GR; Fisk NM; Guillot PV
    Stem Cells Dev; 2014 Feb; 23(3):262-76. PubMed ID: 24028330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Phenylbutyric acid enhances the mineralization of osteogenesis imperfecta iPSC-derived osteoblasts.
    Takeyari S; Kubota T; Ohata Y; Fujiwara M; Kitaoka T; Taga Y; Mizuno K; Ozono K
    J Biol Chem; 2021; 296():100027. PubMed ID: 33154166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Makings of a brittle bone: Unexpected lessons from a low protein diet study of a mouse OI model.
    Mertz EL; Makareeva E; Mirigian LS; Koon KY; Perosky JE; Kozloff KM; Leikin S
    Matrix Biol; 2016; 52-54():29-42. PubMed ID: 27039252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta.
    Infante A; Alcorta-Sevillano N; Macías I; Cabodevilla L; Medhat D; Lafaver B; Crawford TK; Phillips CL; Bueno AM; Sagastizabal B; Arroyo M; Campino A; Gerovska D; Araúzo-Bravo M; Gener B; Rodríguez CI
    Biomed Pharmacother; 2024 Jun; 175():116725. PubMed ID: 38744219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Consequences of the SERPINH1/HSP47 Mutation in the Dachshund Natural Model of Osteogenesis Imperfecta.
    Lindert U; Weis MA; Rai J; Seeliger F; Hausser I; Leeb T; Eyre D; Rohrbach M; Giunta C
    J Biol Chem; 2015 Jul; 290(29):17679-17689. PubMed ID: 26004778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hindlimb Skeletal Muscle Function and Skeletal Quality and Strength in +/G610C Mice With and Without Weight-Bearing Exercise.
    Jeong Y; Carleton SM; Gentry BA; Yao X; Ferreira JA; Salamango DJ; Weis M; Oestreich AK; Williams AM; McCray MG; Eyre DR; Brown M; Wang Y; Phillips CL
    J Bone Miner Res; 2015 Oct; 30(10):1874-86. PubMed ID: 25829218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy in the Col1a2
    Kaupp S; Horan DJ; Lim KE; Feldman HA; Robling AG; Warman ML; Jacobsen CM
    Bone; 2020 Feb; 131():115084. PubMed ID: 31648079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.